Foghorn Therapeutics Inc.FHTXNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.39
Net Income/Share$-1.14
Operating CF/Share$-1.40
Free CF/Share$-1.41
Cash/Share$2.86
Book Value/Share$-1.42
Tangible Book/Share$-1.42
Equity/Share$-1.42
Interest Debt/Share$0.36
CapEx/Share$0.01
Dividend/Share$0.00
Valuation
Market Cap$342.70M
Enterprise Value$275.90M
P/E Ratio-5.11P/S Ratio13.98P/OCF Ratio-4.17
P/FCF Ratio-3.86
P/B Ratio-4.11P/TB Ratio-4.11
EV/Sales11.25EV/EBITDA-3.57
Graham Valuation
Graham Number--
Graham Net-Net$-1.81
Profitability
Earnings Yield-19.56%FCF Yield-25.93%ROE105.48%ROIC-68.32%Return on Tangible Assets-35.19%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-0.60%
CapEx/Revenue2.16%
CapEx/Depreciation0.16
SBC/Revenue32.25%
SG&A/Revenue110.56%
R&D/Revenue338.64%
Liquidity & Solvency
Debt/Equity-0.25Debt/Assets0.11Debt/Market Cap0.07
Net Debt/EBITDA0.86
Current Ratio2.16Interest Coverage0.00xIncome Quality1.22Efficiency
Days Sales Outstanding0 days
Days Payables Outstanding56 days
Days Inventory0 days
Receivables Turnover0.00x
Payables Turnover6.51x
Inventory Turnover0.00x
Capital Structure
Tangible Assets-$89.66M
Working Capital$99.03M
Invested Capital$117.87M
Intangibles/Assets0.00%